Cite
HARVARD Citation
Gillingham, M. et al. (2017). Triheptanoin versus trioctanoin for long‐chain fatty acid oxidation disorders: a double blinded, randomized controlled trial. Journal of inherited metabolic disease. 40 (6), pp. 831-843. [Online].